Disease Etiology and Outcomes After Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma: Post-Hoc Analysis of IMbrave150
Magdalena Espinoza, Maishara Muquith, Mir Lim, Hao Zhu, Amit G. Singal, David Hsiehchen
Topics & Concepts
AtezolizumabMedicineInternal medicineHepatocellular carcinomaBevacizumabScopusOncologyGastroenterologyMEDLINECancerPembrolizumabImmunotherapyChemotherapyLawPolitical scienceHepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and BiomarkersPancreatic and Hepatic Oncology Research